TB-500 timeline: what research and user reports show over 6 weeks

TB-500 is a synthetic fragment of thymosin beta-4, studied for systemic tissue repair rather than a single injury site, and it is frequently discussed alongside BPC-157. As with BPC-157, the strongest controlled data is preclinical, so this keeps published animal findings and reported human experience clearly separate.

What the published research actually studied

TB-500 research covers animal models of wound healing, muscle injury and cardiac tissue repair, generally showing accelerated cell migration to injury sites and new blood vessel formation over one to several weeks depending on the tissue studied. Human trial data at scale does not exist, which matters most for anyone reading a specific human timeline.

Weeks 1 to 2: earliest reports

Reports at this stage most often describe subtle changes in flexibility or a sense of reduced overall stiffness, generally described as more diffuse and systemic than the localized changes reported with BPC-157 alone.

Weeks 3 to 4: the stretch most protocols are built around

This is where reports most consistently describe noticeable change for soft-tissue and recovery-focused goals, generally framed as improved range of motion and faster recovery between training sessions rather than resolution of a specific acute injury.

Weeks 5 to 6: where a typical protocol length lands

Most reported protocols run four to six weeks, sometimes longer for chronic or long-standing issues, mirroring the same fresh-versus-chronic pattern seen in BPC-157 reporting.

Common questions

Is TB-500 usually used with BPC-157? Yes, community reports frequently describe stacking the two for a combined localized and systemic repair approach, though there is no controlled human data isolating what each compound contributes in combination.

Why is most of the evidence animal-based? Like BPC-157, TB-500 has not gone through large controlled human trials, so the strongest data remains preclinical. That is a genuine limitation, not a technicality.

For mechanism, research dosing reference and citations, see the TB-500 reference page. For the localized-repair comparison, see the BPC-157 timeline.